Evidence Hub

Intracerebral haemorrhage associated with collagen type IV alpha 2 gene mutation and familial small vessel disease

Satyadi RS, Connolly DJ, Harkness KA

BMJ case reports, 2026

Abstract

A woman in her late 50s presented with a 2-day history of left-sided headache, confusion and speech disturbance. Neuroimaging revealed a large left parietal-temporal haematoma with surrounding oedema and multiple microhaemorrhages in contralateral brain regions. There was a significant family history of young-onset stroke. Subsequent genetic testing confirmed a pathogenic COL4A2 mutation, consistent with hereditary cerebral small vessel disease. Management included blood pressure optimisation, migraine prophylaxis and cognitive support. This case highlights the importance of considering monogenic causes of intracerebral haemorrhage in patients with atypical imaging and positive family history, enabling early intervention and family screening.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free